AstraZeneca Uses an AI-Generated Llama to Break Pharma's Ad Clichés
Updated: 3 days ago
AstraZeneca has built a 'wonderfully weird' campaign for its COPD inhaler Breztri around an AI-generated animated llama, ditching conventional pharma advertising to make the message more approachable.
What AstraZeneca launched
AstraZeneca has launched a self-described "wonderfully weird" campaign for Breztri, its LAMA/LABA/ICS combination inhaler for chronic obstructive pulmonary disease (COPD), built around an AI-generated animated llama. The character is a deliberate break from the smiling-patient-in-a-meadow conventions of pharma advertising.
The work uses generative AI to make treatment messaging more approachable, and continues AstraZeneca's run of animation-led Breztri advertising.
Why it matters
Pharma is one of the most creatively conservative categories in advertising — bound by regulation, risk-averse by culture, and largely interchangeable as a result. A brand that dares to be distinctive stands out simply by refusing to look like everyone else. A llama is memorable; a stock-photo patient is not.
Our read: the AI angle is doing double duty. It lowers the cost of producing a stylised character world, and it signals that even a heavily regulated pharma giant is comfortable deploying generative tools in market — a notable marker for how fast AI creative is normalising across cautious categories.
What businesses should do
In a category built on sameness, distinctiveness is the cheapest competitive advantage available. You do not need a bigger budget than your rivals; you need the nerve to look different from them. Ask what convention your whole sector follows unthinkingly — then break it.
On AI, take the signal seriously. If a risk-averse, regulated pharma brand is happy to run AI-generated creative, the "is it safe to use in real campaigns" debate is effectively over. The question now is craft and control, not permission — build the review process that lets you use these tools confidently.
Quick FAQ
What is AstraZeneca's Breztri campaign?
A 'wonderfully weird' campaign for its COPD inhaler built around an AI-generated animated llama, breaking from conventional pharma advertising.
Why use an AI-generated character?
It lowers the cost of a stylised character world and makes treatment messaging more approachable, while signalling AstraZeneca's comfort with generative tools.
Why does it matter for other advertisers?
A regulated, cautious pharma brand running AI creative suggests the debate over whether AI is 'safe' for real campaigns is effectively settled.
Pharma is the most conservative category in advertising, so a llama counts as radical — and that's the point. Distinctiveness is the cheapest edge there is. And when a regulated pharma giant runs AI-generated creative, the 'is AI safe for real campaigns' debate is basically over. — Daniel Nikolla, Founder of Merx Marketing
In a category built on sameness, daring to look different is the cheapest advantage there is — and pharma using AI creative shows the technology has crossed into the mainstream.
What convention does your entire industry follow that you'd stand out simply by breaking?
If you would like to know more about this topic, please contact us on danieln@merxmarketing.co.uk
Sources: MediaPost, Fierce Pharma.
Related reading
Written by Daniel Nikolla, Founder of Merx Marketing Ltd and Marketing Minute
Comments